Clinical Trial Update: Artificial Intelligence Driven Personalisation of Radiotherapy and Concomitant Androgen Deprivation Therapy for Prostate Cancer Patients (the HypoPro Trial) [Phase 2]

View source ↗

Summary

The HypoPro trial is a Phase 2 study evaluating AI-driven personalization of radiotherapy in combination with androgen deprivation therapy for prostate cancer; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: German Oncology Center, Cyprus | Conditions: Prostate Cancer | Phase 2 | Status: RECRUITING